Reactive intragastric implant devices

• US 8,956,380 B2
• Filed: 10/18/2011
• Issued: 02/17/2015
• Est. Priority Date: 10/18/2010
• Status: Active Grant

• Current Assignee: Boston Scientific Scimed, Inc. (Boston Scientific Corporation)
• Original Assignee: Apollo Endosurgery, Inc. (Boston Scientific Corporation)
• Inventors: Dominguez, Zachary, Schwab, Justin, Babkes, Mitchell H.
• Primary Examiner(s): MCEVOY, THOMAS M
• Application Number:
  US13/276,182
• Publication Number:
  US 20120095496A1
• Time in Patent Office: 1,218 Days
• Field of Search: 606/191, 606/192, 606/195, 606/198, 623/23.64, 623/23.65
• US Class Current: 606/192
• CPC Class Codes: A61F 5/0033 with more than one chamber
• CPC Class Codes: A61F 5/0036 Intragastrical devices

Abstract

Transoral three-dimensionally orthogonal intragastric spring systems, devices, methods of operation and manufacture are provided. A transoral three-dimensionally orthogonal intragastric spring system and/or device (and related methods of manufacture and operation) may reduce obesity or weight by stimulating the stomach walls of the patient. The three-dimensionally orthogonal intragastric spring device may be a purely mechanical device comprising a flexible body which in response to an input force in one direction, may deform and cause a resultant displacement in an orthogonal direction, thereby exerting a pressure on the inner stomach walls of the patient. Alternatively, a three-dimensionally orthogonal intragastric spring device may include a variable size balloon configured to occupy volume in the patient'"'"'s stomach, thereby reducing the amount of space in the patient'"'"'s stomach.

Claims

1. A reactive implantable device configured to be placed in a patient'"'"'s stomach transorally without surgery to treat and prevent obesity by applying a pressure to the patient'"'"'s stomach, comprising:

a three-dimensional spring structure comprising a plurality of legs each having opposite ends extended between top and bottom junctions of the spring structure defining an axis, each leg having a flexible portion and a rigid portion attached to the flexible portion, wherein the flexible portions of each leg has a relaxed shape which causes the leg to bow laterally outward from the other legs thus maintaining the top and bottom junctions at a first distance apart, and wherein the spring structure is configured to react to inward forces from the stomach such that the flexible portions flex to straighten each leg and cause the axial spacing between the top and bottom junctions to increase from the first distance,

wherein the spring structure is formed of materials that permit it to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach; and

a digestible sleeve or band positioned over at least a portion of the spring structure.

2. The device of claim 1, wherein the implantable device comprises four or more legs.

3. The device of claim 1, wherein rigid portion comprises four or more distinct rigid members per leg.

4. The device of claim 1, wherein each of the top and bottom junctions comprises a quadrilateral-shaped cap, and wherein the opposite ends of each leg are attached to different edges of the respective quadrilateral-shaped caps.

5. The device of claim 1, wherein the digestible sleeve or band is comprised of a sugar.

6. The device of claim 1, wherein the digestible sleeve or band is digestible by stomach acids.

7. The device of claim 6, wherein the sleeve or band is adapted to be digested by stomach acids.

8. The device of claim 7, wherein the sleeve or band is comprised of a sugar.

9. The device of claim 1, wherein the digestible sleeve or band retains the plurality of legs in a straight configuration.

10. The device of claim 1, wherein the plurality of legs are unattached to each other between the opposite closed ends.

11. A reactive implantable device configured to be placed in a patient'"'"'s stomach transorally without surgery to treat and prevent obesity by applying a pressure to the patient'"'"'s stomach, comprising:

a three-dimensional spring structure comprising a plurality of legs each having opposite ends extended between top and bottom closed junctions of the spring structure defining an axis, each leg having a flexible portion and a pair of rigid portions attached to the flexible portion, wherein the flexible portion of each leg has a relaxed shape which causes the leg to bow laterally outward from the other legs at a location longitudinally centrally displaced between the opposite closed ends and such that the rigid portions are on opposite sides of the location longitudinally central displaced, thus maintaining the top and bottom junctions at a first distance apart, and wherein the spring structure is configured to react to inward forces from the stomach such that the flexible portions flex to straighten each leg and cause the axial spacing between the top and bottom junctions to increase from the first distance,

wherein the spring structure is formed of materials that permit it to be compressed into a substantially linear transoral delivery configuration and that will resist degradation over a period of at least six months within the stomach; and

a balloon integrated with the three-dimensional spring structure and filled with fluid.

12. The device of claim 11, wherein the balloon is within the legs of the three-dimensional spring structure.

13. The device of claim 11, wherein the balloon is outside the legs of the three-dimensional spring structure.

14. The device of claim 13, further including a pump located within the balloon and integrated with the three-dimensional spring structure, the pump configured to inflate and deflate the elastic balloon by transferring stomach liquid into and out of the elastic balloon.